Blue Crest Capital Management LTD Catalent, Inc. Transaction History

Blue Crest Capital Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $2.18 Million - $3.38 Million	-72,909 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$40.12 - $45.55 $4.77 Million - $5.41 Million	-118,777 Reduced 61.96%	72,909 $3.32 Million
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $6.92 Million - $7.59 Million	178,615 Added 1366.5%	191,686 $8.03 Million
Q1 2018 May 15, 2018	BUY	$39.4 - $47.39 $514,997 - $619,434	13,071 New	13,071 $537,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.